Rates and impact of human antibody glycation in vivo

Glycobiology

Volumn 22, Issue 2, 2012, Pages 221-234

  Goetze, Andrew M ^a   Liu, Y Diana ^a   Arroll, Thomas ^a   Chu, Lily ^a   Flynn, Gregory C ^a  

^a AMGEN INC   (United States)

Author keywords

effector function; peptide mapping; posttranslational modifications

Indexed keywords

CD16 ANTIGEN; FC RECEPTOR; GLUCOSE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; MONOCLONAL ANTIBODY; POLYPEPTIDE; PROTEIN A; RECOMBINANT ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELUTION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; INCUBATION TEMPERATURE; MASS SPECTROMETRY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; REVERSED PHASE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, REVERSE-PHASE; GLUCOSE; GLYCOSYLATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MASS SPECTROMETRY; PEPTIDE MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, FC; STAPHYLOCOCCAL PROTEIN A; TEMPERATURE;

EID: 84862907501     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwr141     Document Type: Article

References (41)

1. Acharya AS, Sussman LG. 1984. The reversibility of the ketoamine linkages of aldoses with proteins. J Biol Chem. 259:4372-4378. (Pubitemid 14127802)
2. Alyanakian MA, Bernatowska E, Scherrmann JM, Aucouturier P, Poplavsky JL. 2003. Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromes. Vox Sang. 84:188-192. (Pubitemid 36514175)
3. Andersson P, Jesson G, Kylberg G, Ekstrand G, Thorsen G. 2007. Parallel nanoliter microfluidic analysis system. Anal Chem. 79:4022-4030. (Pubitemid 46903150)
4. Austin GE, Mullins RH, Morin LG. 1987. Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. Clin Chem. 33:2220-2224.
5. Baynes JW, Thorpe SR, Murtiashaw MH. 1984. Nonenzymatic glucosylation of lysine residues in albumin. In: Wold F, Moldave K, editors. Posttranslational modifications; Part A, methods in enzymology, vol. 106. New York: Academic Press, Inc. p. 88-98. (Pubitemid 14079122)
6. Brady LJ, Martinez T, Balland A. 2007. Characterization of nonenzymatic glycation on a monoclonal antibody. Anal Chem. 79:9403-9413. (Pubitemid 350276319)
7. Bucola R, Cerami A. 1992. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv Pharmacol. 23:1-33.
8. Bunn HF, Higgins PJ. 1981. Reaction of monosaccharides with proteins: Possible evolutionary significance. Science. 213:222-224. (Pubitemid 11060569)
9. Cho SJ, Roman G, Yeboah F, Konishi Y. 2007. The road to advanced glycation end products: A mechanistic perspective. Curr Med Chem. 14:1653-1671. (Pubitemid 47010154)
10. Dolhofer-Bliesener R, Gerbitz KD. 1990. Impairment by glycation of immu-noglobulin G Fc fragment function. Scand J Clin Lab Invest. 50:739-746. (Pubitemid 20369261)
11. Gadgil HS, Bondarenko PV, Pipes G, Rehder D, McAuley A, Perico N, Dillon T, Ricci M, Treuheit M. 2007. The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. J Pharm Sci. 96:2607-2621. (Pubitemid 47597812)
12. Garlick RL, Mazer JS. 1983. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 258:6142-6146. (Pubitemid 13106789)
13. Holmquist WR, Schroeder WA. 1964. Properties and partial characterization of adult human hemoglobin A1c. Biochim Biophys Acta. 82:639-641.
14. Honda N, Lindberg U, Andersson P, Hoffmann S, Takei H. 2005. Simultaneous multiple immunoassays in a compact disc-shaped microflui-dic device based on centrifugal force. Clin Chem. 51:1955-1961. (Pubitemid 41368195)
15. Jefferis R. 2007. Antibody therapeutics: Isotype and glycoform selection. Expert Opin Biol Ther. 7:1401-1413. (Pubitemid 47475656)
16. Kaneshige H. 1987. Nonenzymatic glycosylation of serum IgG and its effect on antibody activity in patients with diabetes mellitus. Diabetes. 36:822-828. (Pubitemid 17145303)
17. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. 1976. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med. 295:417-420.
18. Lapolla A, Fedele D, Garbeglio M, Martano L, Tonani R, Seraglia R, Favretto D, Fedrigo MA, Traldi P. 2000. Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG. J Am Soc Mass Spectrom. 11:153-159. (Pubitemid 34506433)
19. Ligier S, Fortin PR, Newkirk MM. 1998. A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Br J Rheumatol. 37:1307-1314.
20. Liu YD, Chen X, Enk JZ, Plant M, Dillon TM, Flynn GC. 2008. Human IgG2 antibody disulfide rearrangement in vivo. J Biol Chem. 283:29266-29272.
21. Liu XY, Pop LM, Vitetta ES. 2008. Engineering therapeutic monoclonal antibodies. Immunol Rev. 222:9-27. (Pubitemid 351430363)
22. Liu YD, van Enk JZ, Flynn GC. 2009. Human antibody Fc deamidation in vivo. Biologicals. 37:313-322.
23. Masuda K, Kubota T, Kaneko E, Iida S, Wakitani M, Kobayashi-Natsume Y, Kubota A, Shitara K, Nakamura K. 2007. Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Mol Immunol. 44:3122-3131. (Pubitemid 46610515)
24. McMenamy RH, Lund CC, Oncley JL. 1957. Unbound amino acid concentrations in human blood plasmas. J Clin Invest. 36:1672-1679.
25. Miller AK, Hambly DM, Kerwin BA, Treuheit MJ, Gadgil HS. 2011. Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody. J Pharm Sci. 100:2543-2550.
26. Out TA, McDonald JR, Woldhuis-Kant J, Nieuwenhuys EJ. 1984. The effect of reduction of IgM on the quantitative determination of IgM by radial immunodiffusion and turbidimetry. Clin Chim Acta. 144:115-126. (Pubitemid 15196345)
27. Pan H, Chen K, Chu L, Kinderman F, Apostol I, Huang G. 2009. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci. 18:424-433.
28. Quan C, Alcala E, Petkovska I, Matthews D, Canova-Davis E, Taticek R, Ma S. 2008. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: Where it is, how it got there, and how it affects charge-based behavior. Anal Biochem. 373:179-191.
29. Ryan MH, Petrone D, Nemeth JF, Barnathan E, Bjorck L, Jordan RE. 2008. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol. 45:1837-1846.
30. Sacks DB. 2008. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz Fundamentals in Clinical Chemistry. 6th ed. St Louis: Saunder Elsevier. p. 378-401.
31. Shields R, Namenuk A, Hong K, Meng Y, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, et al. 2001. High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to FcγR. J Biol Chem. 276:6591-6604.
32. Shilton BH, Walton DJ. 1991. Sites of glycation of human and horse liver alcohol dehydrogenase in vivo. J Biol Chem. 266:5587-5592. (Pubitemid 21909534)
33. Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. 2007. Downstream processing of monoclonal antibodies-application of platform approaches. J Chromatogr B Analyt Technol Biomed Life Sci. 848:28-39. (Pubitemid 46367766)
34. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. 2006. Absolute quantification of proteins by LCMSE: A virtue of parallel MS acquisition. Mol Cell Proteomics. 5:144-156. (Pubitemid 43169347)
35. Tai AW, Newkirk MM. 2000. An autoantibody targeting glycated IgG is associated with elevated serum immune complexes in rheumatoid arthritis (RA). Clin Exp Immunol. 120:188-193. (Pubitemid 30176918)
36. Venkatraman J, Aggarwal K, Balaram P. 2001. Helical peptide models for protein glycation: Proximity effects in catalysis of the amadori rearrangement. Chem Biol. 8:611-625. (Pubitemid 32632529)
37. Vlug A, Nieuwenhuys EJ, van Eijk RV, Geertzen HG, van Houte AJ. 1994. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin (Paris). 52:561-567. (Pubitemid 24338810)
38. Watkins NG, Neglia-Fisher CI, Dyer DG, Thorpe SR, Baynes JW. 1987. Effect of phosphate on the kinetics and specificity of glycation of protein. J Biol Chem. 262:7207-7212.
39. Yan B, Valliere-Douglass J, Brady L, Steen S, Han M, Pace D, Elliott S, Yates Z, Han Y, Balland A, et al. 2007. Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry. J Chromatogr A. 1164:153-161. (Pubitemid 47284102)
40. Zhang Z. 2004. De novo peptide sequencing based on a divide-and-conquer algorithm and peptide tandem spectrum simulation. Anal Chem. 76:6374-6383. (Pubitemid 39458471)
41. Zhang B, Yang Y, Yuk I, Pai R, McKay P, Eigenbrot C, Dennis M, Katta V, Francissen KC. 2008. Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody. Anal Chem. 80:2379-2390. (Pubitemid 351499819)